Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


May 7-10, 2018
Hynes Convention Center,
Boston, MA


TIDES Offers the Science, Technologies and Partners You Need to Grow Your Business


Fast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma, biotechs, academia and solution providers from North America, Asia and Europe.


Hear best practices, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production.


Connect with leading manufacturing, technologies, and service providers to drive your promising therapeutic towards commercial success.

TIDES Highlight Video

See what past TIDES attendees had to say about their onsite experience!

cross-fertilize ideas and best practices with researchers from different disciplines

Oligonucleotide Tracks
  • Chemistry, Manufacturing & Controls: Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.
  • Discovery, Preclinical and Clinical: Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.
Peptide Tracks
  • Chemistry, Manufacturing & Controls: Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.
  • Discovery, Preclinical and Clinical: Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.
New at TIDES 2018
  • 8 Pre-Conference Half Day Workshops
    Gain the insight you need to accelerate your molecule to market by attending one of our eight pre-conference workshops led by a member of the TIDES advisory board.
  • Fireside Chat: The Emergence of CRISPR Therapeutics
    Executives from CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics discuss how innovations in CRISPR technology are being utilized to develop today’s novel therapeutics.
  • Delivery of Macromolecular Therapeutics
    Ensure efficacy in your therapeutic by cross-fertilizing ideas with delivery experts working across oligonucleotides, peptides, mRNA and CRISPR.
  • CMC Regulatory Panel Discussion
    Ensure accurate CMC submissions by gaining regulatory guidance in this interactive discussion with panelists representing Eli Lilly, Biogen and BfArM.
  • Back in Boston!
    Returning to Boston for the first time since 2013, TIDES now attracts more than 1,000+ global scientists and executives working across the entire spectrum of oligonucleotide and peptide development.

TIDES 2018 Pre-Conference Workshops

Mass Spectrometry for Peptides and Oligonucleotides

Workshop Moderator: Fanyu Meng, Ph.D., Principal Scientist, Analytical Research and Development, Merck Research Labs, Merck & Co., Inc.

An Introduction to messengerRNA (mRNA) Therapeutics

Workshop Moderator: James Thompson, Ph.D., Head CMC Project Management, Moderna Therapeutics

Risk-based Approaches to CMC Development of Therapeutic Oligonucleotides

Workshop Moderators: G. Susan Srivatsa, Ph.D., President, ElixinPharma and Fran Wincott, Ph.D., Wincott & Associates, LLC

Novel Synthetic Technologies for Manufacturing Peptides

Workshop Moderator: Trishul Shah, Associate Director, Business Development, North America, PolyPeptide

Peptide Aggregation Challenges from API to Drug Product

Workshop Moderator: Trishul Shah, Associate Director, Business Development, North America, PolyPeptide

An Introduction to CRISPR and Genome Editing Applications

Workshop Moderator: Cecilia Fernández, Ph.D., Senior Director, Platform Strategy and Operations, Editas Medicine

Lessons from the Peptide Field that Can be Applied to Oligonucleotides

Workshop Moderator: Kevin Fettes, Ph.D., Founder and Principal, FTS Pharma Consulting

The Path to a Successful Oligonucleotide IND/IMPD Submission: Regulatory, Nonclinical and CMC Perspectives

Workshop Moderator: Jennifer Lockridge, Ph.D., SVP, Program Development, Dicerna Pharmaceuticals, Inc.

Present at Scientific Poster at TIDES 2018

Share your company's new research by presenting a poster at TIDES 2018.  All posters are displayed in the exhibit & poster hall area throughout the event.

Please note that all poster presenters must be registered attendees.  The deadline to submit your abstract is April 6, 2018.

TIDES Tube - Watch Past Keynote Presentations

TIDES Tube provides the global oligonucleotide and peptide community with exclusive video content designed to help accelerate promising therapeutics from early discovery to late-stage development & commercialization.

Check out TIDES Tube now to watch video of last year's keynote presentations.

Do you want to highlight your company's expertise in TIDES Tube?  Contact us today!

Connect with Key Buyers at TIDES 2018 in Boston